
Riax-S 250mg/125mg Injection
Marketer
Totem Biotech Pvt Ltd
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Riax-S 250mg/125mg Injection
Combiflox 250mg/125mg Injection, a dual-action antibiotic, combats diverse bacterial infections by inhibiting microbial proliferation and halting infection spread. Administration must be under a doctor's guidance; strict adherence to the prescribed schedule is crucial, completing the entire course regardless of symptom improvement. Premature cessation may reduce its effectiveness. Potential side effects include nausea, vomiting, diarrhea, and indigestion. Worsening side effects require immediate medical attention. Seek immediate medical help for allergic reactions (rash, itching, swelling, breathlessness). Inform your physician of all medications before use. Pregnant or lactating individuals should consult their doctor. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing, driving should be avoided if drowsiness or dizziness occurs. Adequate rest, a balanced diet, and sufficient hydration are recommended for optimal recovery. Your doctor may order blood tests and other assessments to monitor treatment response.
Primary Ingredients of Riax-S 250mg/125mg Injection
The provided text is "undefined," which lacks meaning and cannot be rephrased. Therefore, no rewritten text can be provided.
Uses of Riax-S 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Riax-S 250mg/125mg Injection:
Administering this medication is the responsibility of your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Riax-S 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Riax-S 250mg/125mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
How Riax-S 250mg/125mg Injection works:
The injectable formulation Riax-S (250mg/125mg) merges Ceftriaxone, a crucial antibiotic, with Sulbactam, a beta-lactamase inhibitor. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, a process vital for bacterial viability. Sulbactam's role is to counteract bacterial resistance mechanisms, thereby optimizing Ceftriaxone's antibacterial effect.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Riax-S 250mg/125mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Riax-S, 250mg/125mg, is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, data from human trials remain scarce.
Breast feedingCAUTION
The administration of Riax-S 250mg/125mg Injection necessitates careful consideration in breastfeeding mothers. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Riax-S 250mg/125mg Injection can potentially reduce attentiveness, impair vision, and induce drowsiness or dizziness. Driving should be avoided if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Riax-S 250mg/125mg Injection to individuals with renal impairment. Seek medical advice.
LiverCAUTION
The injectable medication Riax-S 250mg/125mg requires careful administration in individuals with significant hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Dosage alterations for Riax-S 250mg/125mg Injection are not suggested for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Riax-S 250mg/125mg Injection :
Should you omit a scheduled dose of Riax-S 250mg/125mg Injection, seek medical advice.
Facts to Know About Riax-S 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
